Cationic modulation of human dopamine transporter: Dopamine uptake and inhibition of uptake

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 940-949

  Chen, Nianhang ^a,b   Trowbridge, Clarence G ^b   Justice Jr , Joseph B ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CHOLINE; COCAINE; DOPAMINE; LITHIUM; MAZINDOL; METHYLPHENIDATE; SODIUM ION; TYRAMINE; VANOXERINE;

ARTICLE; BINDING KINETICS; CATION TRANSPORT; DOPAMINE RELEASE; DRUG POTENCY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MATHEMATICAL ANALYSIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; REACTION ANALYSIS;

CARRIER PROTEINS; CATIONS, MONOVALENT; CELLS, CULTURED; CHOLINE; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ELECTRODES; HUMANS; KIDNEY; KINETICS; LITHIUM; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METALS, ALKALI; NERVE TISSUE PROTEINS; POTASSIUM; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; SODIUM;

EID: 0032773515     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16:73-93.
2. + dependence of the neuronal transporter of dopamine. J Neurochem 59:1795-1840.
3. Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504.
4. Bönisch H (1998) Transport and drug binding kinetics in membrane vesicle preparation. Methods Enzymol 296:259-278.
5. Burnette WB, Bailey MD, Kukoyi S, Blakely RD, Trowbridge CG and Justice Jr. JB (1996) Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal Chem 68:2932-2938.
6. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester to the dopamine transporter. J Neurochem 68:1968-1981.
7. 125I]3β-(iodophenyl)tropane-2β-carboxylic acid isopropyl ester to the dopamine transporter at a physiological relevant temperature: Mutually exclusive binding and different ionic requirements for various uptake blockers and substrates. Synapse 25:155-162.
8. Chen NH and Justice Jr JB (1998) Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter:Kinetic analysis of inward and outward transport. J Neurosci 18:10257-10268.
9. Chen NH, Trowbridge CG and Justice Jr JB (1998) Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter. J Neurochem 71:653-665.
10. Do-Régo J-C, Hue H, Costentin J and Bonnet J-J (1998) Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783[1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine] and the neuronal transporter of dopamine. J Neurochem 72:396-404.
11. Earles C and Schenk JO (1999) A multisubstrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine. Synapse, in press.
12. Eshleman AJ, Neve RL, Janowsky A and Neve KA (1995) Characterization of a recombinant human dopamine transporter in multiple cell lines. J Pharmacol Exp Ther 274:276-283.
13. Eshleman AJ, Setwart E, Evenson AK, Mason JN, Blakely RD, Janowsky A and Neve KA (1997) Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J Neurochem 69:1459-1466.
14. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond) 379:606-612.
15. Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D and Korszun A (1997) Replacement medication for cocaine dependence: Methylphenidate. J Clin Psychopharmacol 17:485-488.
16. Gu H, Wall S and Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130.
17. 3H]GBR12783 binding to the dopamine neuronal carrier. Eur J Pharmaocl 301: 195-202.
18. Krueger BK (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J Neurochem 55:260-267.
19. Levi G and Raiteri M (1993) Carrier-mediated release of neurotransmitters. Trend Neurosci 16:415-419.
20. 3H]WIN35,428 to the human dopamine transporter. J Neurochem 72:1095-1109.
21. McElvain JS and Schenk JO (1992) A multisubstrate mechanism for uptake of striatal dopamine and its inhibition by cocaine. Biochem Pharmacol 43:2189-2199.
22. Munson PJ and Rodbard D (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
23. - of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters. Br J Pharmacol 121:205-212.
24. Povlock SL and Schenk JO (1997) A multisubstrate kinetic mechanism of dopamine transporter in the nucleus accumbens and its inhibition by cocaine. J Neurochem 69:1093-1105.
25. 3H]GBR12,935 binding. Mol Pharmacol 45:125-135.
26. 3H]tropane to the dopamine carrier. J Neurochem 61:167-177.
27. Reith MEA, de Costa B, Rice KC and Jacobson AE (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR12935, and dopamine to the dopamine transporter. Eur J Pharmacol 227:417-425.
28. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
29. Rudnick G (1997) Mechanisms of biogenic amine neurotransmitter transporters, in Neurotransmitter Transporter: Structure, Function, and Regulation (Reith MEA ed) pp 73-100, Humana Press, Totowa.
30. Rudnick G (1998) Ion-coupled neurotransmitter transport: Thermodynamic vs kinetic determinations of stoichiometry. Methods Enzymol 296:233-247.
31. Segel IH (1993) Enzyme Kinetic: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, John Wiley and Sons, New York.
32. Shank RP, Schneider CR and Tighe JJ (1987) Ion dependence of neurotransmitter uptake inhibitory effects of ion substitutes. J Neurochem 49:381-388.
33. Sitte HH, Huck S, Reither H, Boehm S, Singer EA and Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289-1297.
34. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP and Amara SG (1997) Multiple ionic conductance of the human dopamine transporter: The action of dopamine and psychostimulants. J Neurosci 17:960-974.
35. Stein WD (1986) Transport and Diffusion Across Cell Membranes, Academic Press, San Diego.
36. Tatsumi M, Groshan K, Blakely RD and Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
37. Uhl GR and Johnson PS (1994) Neurotransmitter transporter: Three important gene families for neuronal function. J Exp Biol 196:229-236.
38. Wheeler DD, Edwards AM, Chapman BM and Ondo JG (1993) A model of the sodium dependence of dopamine uptake in rat striatal synaptosomes. Neurochem Res 18:927-936.
39. 3H]WIN35,428 binding to the human dopamine transporter in a similar fashion. J Neurochem 69:1106-1118.
40. Zhang Y (1998) The identification of GBR12909 as a potential therapeutic agent for cocaine abuse. Med Chem Res 8:66-76.